v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (288,249) $ 13,993
Adjustments to reconcile net (loss) income to net cash flow from operating activities    
Stock-based compensation 50,913 44,279
Depreciation and amortization 19,417 17,542
Accretion of available-for-sale securities premiums/discounts (4,122) (4,545)
Amortization of convertible notes issuance costs 1,423 0
Realized gain on investments (36) 0
Non-cash interest expense on liability related to the sale of future royalties 25,115 18,893
Non-cash interest expense on credit facility 44,374 48,774
Loss on equity method investment 9,190 0
Gain on VIE's sale of IPR&D assets (19,000) 0
Non-cash transfer of property and equipment to affiliate 579 0
Changes in operating assets and liabilities:    
Accounts receivable (1,907) (9,841)
Prepaid expenses and other current assets (29,940) (22,342)
Accounts payable 9,980 21,662
Accrued expenses (15,214) 7,956
Deferred revenue 123,940 22,979
Operating lease, net (3,556) (3,417)
Other (2,453) 3,128
Net cash (used in) provided by operating activities (79,546) 159,061
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (8,567) (15,177)
Purchases of available-for-sale securities (1,138,714) (774,616)
Proceeds from sales of available-for-sale securities 48,788 0
Proceeds from maturities of available-for-sale securities 224,152 587,880
Net cash used in investing activities (874,341) (201,913)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the exercises of stock options 12,763 3,476
Proceeds from issuance of warrants 99,998 25,000
Proceeds from issuance of convertible notes 700,000 0
Payments of debt issuance costs (18,716) (5,000)
Purchase of capped calls (47,880) 0
Repayments of credit facility (117,891) (201,625)
Proceeds from Visirna credit agreement 0 7,098
Dividends paid by variable interest entity to noncontrolling shareholders (38,434) 0
Net cash provided by financing activities 780,518 70,337
Net (decrease) increase in cash, cash equivalents and restricted cash (173,369) 27,485
Effect of exchange rate on cash, cash equivalents and restricted cash 1,580 (377)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH:    
BEGINNING OF PERIOD 226,548 102,685
END OF PERIOD 54,759 129,793
Supplemental disclosure of cash flows:    
Interest paid 0 (19)
Income taxes paid (21,587) (81)
Supplemental disclosure of non-cash investing activities:    
Capital expenditures included in accrued expenses 1,084 346
Supplemental disclosure of non-cash financing activities:    
ROU assets obtained in exchange for new lease liabilities 13,410 0
ATM Agreement    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 76,109 241,388
Payments of issuance costs of common stock (2,038) 0
Underwriting Public Offering    
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 130,000 0
Payments of issuance costs of common stock $ (13,393) $ 0